Become a member
Quick Registration
Full Registration Benefits -
Free Homepages for Doctors
Free Homepages for Hospitals
Free Homepages for Medical Conference
Free Homepages for NGO's
Personal Health Record Creation
Access to all Medical Slides
Access to all Jobs & Products Sale
Comparison of Apixaban and Aspirin in Preventing Stroke | |
|
| |
Apixaban, a
drug undergoing clinical trials is more effective than and as safe as aspirin
in preventing stroke in patients with atrial fibrillation, according to a
recently published study.
Aspirin is a time-tested drug used as a painkiller and for fever. Besides, low-dose aspirin is used to prevent clotting of blood within the blood vessels. It brings about this action by preventing clumping of platelets.
Apixaban is a new drug currently undergoing clinical trials. It prevents clotting by a different mechanism. It acts by inhibiting the clotting factor Xa, an important protein in the clotting process.
The heart normally beats at a regular rate and rhythm. Atrial fibrillation is a condition where the upper chambers of the heart do not beat regularly. Thus, irregular signals pass through the lower chambers, resulting in irregular heartbeats. The process results in stagnation of blood within the heart and formation of blood clots. The clots can travel to the brain resulting in stroke. They may also travel through the blood (where they are referred to as emboli) and block the blood supply to important organs like heart and lungs.
A study compared the benefits of apixaban with aspirin in patients with or without previous stroke or transient ischemic attacks (TIAs) but unable to take anti-clotting medications like warfarin. Patients received either 5 mg of apixaban twice daily or 81 to 324 mg of aspirin per day. The patients were followed for a little over 1 year. They were monitored for side effects like bleeding.
In patients with a previous stroke or TIA, 10 events of stroke or embolism occurred in the total 390 patients receiving apixaban. In contrast, 33 events were noted in 374 patients receiving aspirin. In those without previous stroke or TIA, these events were 41 in the apixaban group, a total of 2417 patients compared to 80 in the aspirin group, a total of 2415 patients.
The incidence of bleeding between the aspirin and the apixaban groups was not significantly different.
Thus, the benefit of apixaban was much higher compared to aspirin in patients with atrial fibrillation regardless of whether the patient suffered from prior stroke or TIA.
However, further long term studies will be required to establish the role of apixaban in patients with atrial fibrillation. Also, the cost aspect will have to be kept in mind since aspirin is a very cheap drug whereas apixaban is likely to be expensive once it comes into the market.
Reference:
1. Apixaban versus aspirin in patients with atrial fibrillation and previous stroke or transient ischemic attack: a predefined subgroup analysis from AVERROES, a randomised trial; Hans Christoph et al; The Lancet Neurology 2012
Source-Medindia
| |
|
|
More News on: Diet Lifestyle and Heart Disease, Chemotherapy, Mitral Valve Stenosis And Mitral Valve Replacement, Chemotherapy Drugs, Congenital Heart Disease, Stress and the Gender Divide, Stroke Facts, Stroke, Geriatry-Related Diseases, Hyperventilation
 Comment & Contribute
|
Related Links
Acute evaluation and management of ischemic stroke-1 - Introduction
Distance Education for Acute evaluation and management of ischemic ...
Stroke - Top Ten Facts
Stroke is the third most common cause of death and the most prominent cause of physical deformity in the ...
Apixaban Superior To Warfarin In Preventing Stroke
A large-scale trial finds that patients with atrial fibrillation treated with apixaban, a new anticoagulant drug, had fewer strokes and systemic ...
Health In Focus News
Strenuous Working Environment Leads to Diabetes
According to the scientists working in strenuous environment, healthy individuals too are exposed to the threat of developing diabetes. ...
Discarded Kidneys Can Be Used to Generate New Kidneys for Transplantation - Dawn of a New Era in Regenerative Medicine Research
Researchers at Wake Forest Baptist Medical Center in the USA found that human kidneys discarded for transplant can potentially serve as a ...
Flavored Toothbrush for a Pleasant Morning
Toothbrushes are all set to take up a new role. They may soon deliver your morning coffee and get you up and alert even faster. Even more ...
Science Behind the Placebo Effect
Probably the most controversial, yet amazing aspect of medicine is the placebo effect. The idea that somehow, a simple sugar pill, or a drugless ...
Exposure to Toxic Waste can Ruin Health in Kids
Children dwelling at places with abundance of toxic waste in Indonesia, India and Philippines may develop high quantities of lead in their blood ...
Media Reports on Health Hazards May Affect the Health of Some People
Media reports on the adverse effects of substances or technologies can actually trigger the symptoms in some people who read the report, even ...
- Health News Index
 | Quiz on Stroke Stroke is the third leading cause of death world over. Here is a quiz that tests if you know enough about this disabling condition. 
|
- News Quick Links
 | News Central | | Health Watch | |
| Latest Health News | | Health In Focus | |
| News Category (500+) | | Breaking Health News | |
| Popular News | | Celebrating Life | |
| Health News and Press Release | | Medindia - Exclusive | |
| News Photo Gallery | | India Special | |
| News Video Gallery | | Lifestyle and Wellness | |
| News From Other Resources | |||
 |
Stroke
Complete Medindia Resources
|
| News Categories: |
| » | Video Games Featuring Human-Like Enemy More Likely to Provoke Aggression |
| » | Regular Exposure to Both Wood and Tobacco Smoke Poses Greater Risk of COPD |
| » | Botox Captures the Imagination of Pretty Young People |
| » | Australian Study: Social Network Addiction Taking Over Lives |
| » | Electric Lighting Hampers Proper Sleep at Night |
| More Life Style News | |
|
Ask an Expert
